Cipher Pharmaceuticals Inc.
CPHRF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $33 | $21 | $21 | $22 |
| % Growth | 57.7% | 2.4% | -5.8% | – |
| Cost of Goods Sold | $9 | $4 | $4 | $4 |
| Gross Profit | $24 | $17 | $17 | $18 |
| % Margin | 72.2% | 80.8% | 80.7% | 83.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $11 | $5 | $4 | $0 |
| SG&A Expenses | $12 | $5 | $6 | $5 |
| Sales & Mktg Exp. | $2 | $1 | $1 | $0 |
| Other Operating Expenses | $4 | $0 | $0 | $1 |
| Operating Expenses | $16 | $6 | $6 | $6 |
| Operating Income | $8 | $12 | $11 | $12 |
| % Margin | 23.5% | 54.5% | 53.6% | 53.9% |
| Other Income/Exp. Net | -$5 | $1 | -$1 | -$2 |
| Pre-Tax Income | $3 | $13 | $11 | $11 |
| Tax Expense | -$9 | -$8 | -$15 | $3 |
| Net Income | $12 | $20 | $27 | $8 |
| % Margin | 34.6% | 96.3% | 128.8% | 35.4% |
| EPS | 0.47 | 0.82 | 1.01 | 0.29 |
| % Growth | -42.7% | -18.8% | 248.3% | – |
| EPS Diluted | 0.46 | 0.8 | 0.99 | 0.29 |
| Weighted Avg Shares Out | 25 | 25 | 25 | 27 |
| Weighted Avg Shares Out Dil | 25 | 25 | 26 | 27 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $2 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $4 | $1 | $1 | $1 |
| EBITDA | $12 | $12 | $12 | $14 |
| % Margin | 35.6% | 54.5% | 57.8% | 62.2% |